Neurocrine Biosciences, Inc.

NasdaqGS-NBIX

OverviewFinancialsInvestor RelationsResearchEstimatesNewsOwnershipIndustryDividendsModelingFilings

Operating Activities	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Net Income	428	341.3	249.7	154.5	89.6	407.3	37	21.1	-142.5	-141.1	-88.9
Net Income
Depreciation & Amortization	29.7	27.1	21.3	15.6	10.9	8.6	7.4	4	2.4	1.5	1
Depreciation and Amortization
Depreciation
Amortization of Intangible Assets
Stock Based Compensation	225.7	195.5	194.3	173.1	134.2	100	75.3	58.1	42.5	28.5	28.4
Stock-Based Compensation Expense
Other Adjustments	129.6	50.7	-103.6	63.6	5.1	-249.5	32.1	19.9	12.1	-0.8	2.6
Deferred Rent
Asset Impairment
Loan Forgiveness on Notes Receivable
Gain on Sale of Assets, Net
Loss on Sale of Investments
Cash Flow from Operating Activities > Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities > Fair Value Adjustment of Auction Rate Securities
Realized Gain on Sale of Auction Rate Securities
Other-Than-Temporary Impairment for Auction Rate Securities
Cease-Use Expense
Charges Associated with Convertible Senior Notes
Amortization of Premium on Investments, Net
Amortization of Debt Discount
Amortization of Debt Issuance Costs
Accretion of Discount on Available-for-Sale Debt Securities, Net
Changes in Fair Values of Equity Investments
Other, Net
Deferred Income Taxes
Other
Changes in Trade Receivables	-246.9	-39.8	-89.3	-162.2	-28.4	-30.5	-69.2	-25.1	-31.1	—	—
Accounts Receivable
Changes in Inventories	-23.5	-19.1	5.4	-2.6	-2.5	-10.7	-6.4	-3.5	-1	—	—
Inventory
Changes in Accounts Payable	29	29	64.3	114.6	56.8	26.9	54	24.2	27.3	4.4	9.8
Change in Accounts Payable and Accrued Liabilities
Changes in Unearned Revenue	—	—	—	—	—	—	—	—	—	—	10.2
Deferred Revenues
Changes in Other Operating Activities	19.6	10.7	47.8	-17.2	-9.2	-23.6	16.8	2.7	-4	1.4	-1.1
Other Non-Current Assets
Other Current Assets
Other Liabilities
Other Current Assets and Liabilities, Net
Other Assets and Liabilities, Net
Other Non-Current Liabilities
Cash from Operating Activities	636.8	595.4	389.9	339.4	256.5	228.5	147	101.4	-94.3	-106.2	-38
Cash Flows from Operating Activities

Investing Activities	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Capital Expenditure	-43.7	-38.2	-28.3	-16.5	-23.4	-10.9	-14.7	-24.8	-6.9	-4.1	-1.9
Capital Expenditures
Proceeds from Sale of Property, Plant & Equipment	—	—	—	—	—	—	—	—	0	0	0
Proceeds from Sales of Property and Equipment
Purchases of Investments	-1,308.6	-1,056.1	-1,379.9	-628.9	-804.7	-735.5	-866.1	-545.9	-583.4	-298.8	-449.1
Purchases of Available-for-Sale Debt Securities
Purchases of Equity Investments
Proceeds from Sale of Investments	1,072.5	967.5	972.4	511	697.9	750.5	669.7	327.8	339.1	415.8	255.1
Sales and Maturities of Available-for-Sale Debt Securities
Payments for Business Acquisitions	—	—	-31.3	-42.7	—	—	—	—	—	—	—
Acquisition of Business, Net of Cash Acquired
Other Investing Activities	—	—	—	—	—	—	—	—	—	—	0
Deposits and Restricted Cash
Cash from Investing Activities	-279.8	-126.8	-467.1	-177.1	-130.2	4.1	-211.1	-242.9	-251.3	113	-195.8
Cash Flows from Investing Activities

Financing Activities	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Issuance of Long-Term Debt	—	—	—	—	—	—	—	—	502.8	—	—
Proceeds from Issuance of Convertible Senior Notes, Net
Repayments of Long-Term Debt	—	-308.8	—	-279	-0.1	-186.9	—	—	—	—	—
Principal Payments on Debt
Payments to Settle Convertible Senior Notes
Net Issuance / (Repayments) of Long-Term Debt	—	-308.8	—	-279	-0.1	-186.9	—	—	502.8	—	—
Issuance of Common Shares	102.1	122.1	65.3	44.7	27.5	29.1	32.4	29.5	13.9	2.4	277
Issuances of Common Stock Under Benefit Plans
Repurchases of Common Shares	—	-300	—	—	—	—	—	—	—	—	—
Repurchases of Common Stock
Net Issuance / (Repurchases) of Common Shares	102.1	-177.9	65.3	44.7	27.5	29.1	32.4	29.5	13.9	2.4	277
Other Financing Activities	—	—	—	—	—	—	—	—	—	—	—
Leaseback Financing Obligation
Payments Received on Notes Receivable from Employees
Cash from Financing Activities	-365.6	-486.7	65.3	-234.3	27.4	-157.8	32.4	29.5	516.6	2.4	277
Cash Flows from Financing Activities

Free Cash Flow	LTM	Dec '24	Dec '23	Dec '22	Dec '21	Dec '20	Dec '19	Dec '18	Dec '17	Dec '16	Dec '15
Free Cash Flow	593.1	557.2	361.6	322.9	233.1	217.6	132.3	76.6	-101.3	-110.3	-39.9
NOPAT	377	412.7	182.8	168.2	87.5	467	60.8	35.6	-131.4	-147.4	-94.2
Levered Free Cash Flow	439.1	42	360.2	-30.6	122.1	210.7	94.1	23.7	378	-138	-70.9
Unlevered Free Cash Flow	388.1	422.2	293.3	262.1	120.1	457.3	117.9	38.2	-113.6	-144.2	-76.2
Net Change in Cash	-8.6	-18.1	-11.9	-72	153.7	74.8	-31.7	-112	171.1	9.2	43.2